1-855-378-42281-855-378-4228
One of the out-patient rehab alternatives for clients in Higgins who are battling with opioid abuse and addiction is opioid maintenance therapy. Licensed clinics and doctors are certified to administer specific medications to opioid addicted individuals, many of which are opioid-based themselves and are addiction. With low amounts however, the client doesn't feel high and also does not experience severe cravings and is not experiencing opioid withdrawal. Methadone is the first medication administered for this sole purpose, but there are alternative choices currently to pick from.
Methadone is an opiate and is meant to be taken at an out-patient medical center licensed to dispense the med, which is taken on a daily basis as a pill or liquid. The price of the med is approximately $150 a month. Buprenorphine is also an opioid-based drug, and is in pill form often taken every other day. But different from Methadone that is only be dispensed in highly well-regulated medical centers, Buprenorphine can be prescribed and administered in doctor's offices. The price monthly of buprenorphine is approximately just under $300 /month for the generic version of the med. There is also a version of buprenorphine that contains naloxone, which is a med which reverses the effects of opioids. Someone taking this version of the drug, AKA Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It too is taken daily, and is priced about $450 monthly. Naltrexone is another medication taken in opioid maintenance therapy, but unlike the other medications mentioned here it's an opioid blocker and is not an opiate. There is an option to take this medication as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents a person from experience high feelings from opioids, and in turn lowers the risk associated with relapse. This daily shot costs in the range of $1000 to $1200 /month.
For All Alcohol and Drug Rehab Programs In Higgins, Click Here.
